V. Kalyanaraman

发表

Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein GP120 of human immunodeficiency virus.

N. Chirmule, N. Oyaizu, S. Pahwa, 1990, Blood.

Leukemia-Lymphoma Virus ( HTLV ) : A Progress Report

M. Reitz, R. Gallo, F. Wong-Staal, 2005 .

The lectin jacalin induces phosphorylation of ERK and JNK in CD4+ T cells

S. Pahwa, V. Kalyanaraman, S. Tamma, 2003, Journal of leukocyte biology.

Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection.

D. O’Connor, D. Venzon, M. Robert-Guroff, 2008, Vaccine.

Infection and transformation of fresh human umbilical cord blood cells by multiple sources of human T‐cell leukemia‐lymphoma virus (HTLV)

R. Gallo, P. Sarin, S. Salahuddin, 1983, International journal of cancer.

Requirement of the T cell receptor for antigen presentation by T lymphocytes. Effect of envelope glycoproteins of HIV‐1 on antigen presentation by T cells

N. Chirmule, N. Oyaizu, S. Pahwa, 1990, Clinical and experimental immunology.

Polyvalent DNA prime and envelope protein boost HIV‐1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate

J. Mascola, D. Montefiori, Shixia Wang, 2005, Journal of medical primatology.

Serological confirmation of human T-lymphotropic virus type I infection in healthy blood and plasma donors.

J. Epstein, M. Lairmore, D. Slamon, 1989, Blood.

Lack of evidence of circulating retroviral antibodies in patients with classic Hodgkin's disease

T. Chorba, R. Schulof, V. Kalyanaraman, 1988, American journal of hematology.

HIV-gp 160-induced T cell-dependent B cell differentiation. Role of T cell-B cell activation molecule and IL-6.

S. Lederman, L. Chess, N. Chirmule, 1993, Journal of immunology.

Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).

D. Francis, P. Feorino, J. Mcdougal, 1985, Journal of immunological methods.

Localization of B-cell stimulatory activity of HIV-1 to the carboxyl terminus of gp41.

J. Ghrayeb, N. Chirmule, F. Wong-Staal, 1990, AIDS research and human retroviruses.

Human T‐cell leukemia virus (HTLV‐I) p24 antibody in New York City blood product recipients

J. Jason, B. Evatt, J. Mcdougal, 1985, American journal of hematology.

Display of a Peptide Corresponding to the Dimer Structure of Protease Attenuates HIV-1 Replication

I. Weber, C. Goldsmith, A. Srinivasan, 2001 .

HIV-1 gp160 as a modifier of Th1 and Th2 cytokine response: gp160 suppresses interferon-gamma and interleukin-2 production concomitantly with enhanced interleukin-4 production in vitro.

N. Oyaizu, R. Hu, S. Pahwa, 1994, Clinical immunology and immunopathology.

Continuous production of a cytopathic human T-lymphotropic virus in a permissive neoplastic T-cell line

D. Hicks, J. Heath, V. Kalyanaraman, 1986, Journal of clinical microbiology.

Antibodies against three purified structural proteins of the human type‐C retrovirus, HTLV, in Japanese adult T‐cell leukemia patients, healthy family members, and unrelated normals

Y. Ito, R. Gallo, Yōhei Itō, 1983, International journal of cancer.

Signals transduced through the CD4 molecule on T lymphocytes activate NF-kappa B.

N. Chirmule, S. Pahwa, V. Kalyanaraman, 1994, Biochemical and biophysical research communications.

Failure to demonstrate (cross-reacting) antibodies to human T lymphotropic viruses in patients with rheumatic diseases.

M. Kennedy, V. Kalyanaraman, J. McDougal, 1985, Arthritis and rheumatism.

Inhibitory influences of envelope glycoproteins of HIV-1 on normal immune responses.

N. Chirmule, N. Oyaizu, S. Pahwa, 1988, Journal of acquired immune deficiency syndromes.

Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas

P. Bunn, J. Minna, M. Robert-Guroff, 1981, The Journal of experimental medicine.

healthy blood and plasma donors Serological confirmation of human T-lymphotropic virus type I infection in

D. Slamon, B. Poiesz, C. Saxinger, 2011 .

HTLV-I Antibody Status in Hemophilia Patients Treated with Factor Concentrates Prepared from U.S. Plasma Sources and in Hemophilia Patients with AIDS

D. Lawrence, J. Jason, B. Evatt, 1985, Thrombosis and Haemostasis.

Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein GP120 of human immunodeficiency virus.

N. Chirmule, N. Oyaizu, S. Pahwa, 1990, Disease markers.